Richard Marx Recalls His Battle With the Chinese Mafia in New Memoir rollingstone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rollingstone.com Daily Mail and Mail on Sunday newspapers.
Startup Interline snares $92M from Foresite, ARCH to turn protein communities against common diseases bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
We often think of proteins as isolated targets for drugs, says Zach Sweeney, Ph.D., a biopharma veteran who most recently was chief scientific officer at Denali Therapeutics. But it's more complicated than that. Enter Interline Therapeutics, which launches with $92 million to develop drugs that alter protein communities to treat disease.
Interline Therapeutics Raises $92M in Funding
The round was led by Foresite Capital and ARCH Venture Partners.
The company intends to use the funds to expand the research platform and advance six preclinical therapeutic programs.
Co-founded by CEO Zachary Sweeney, Interline Therapeutics is a Foresite Labs incubated company that focuses on systematically elucidating protein communities to define molecular mechanisms of disease.
The company uses genomics, proteomics, structural biology and computational chemistry to systematically map and modulate protein communities. Interline Therapeutics is leveraging recent advancements in these technologies, as well as collaborations with academic groups, to develop a precision medicine platform focused on three essential areas:
In search of a more holistic approach to learning measurement irishnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from irishnews.com Daily Mail and Mail on Sunday newspapers.